🇺🇸 FDA
Pipeline program

6-Thio-2'-Deoxyguanosine

THIO-101

Phase 3 small_molecule active

Quick answer

6-Thio-2'-Deoxyguanosine for Carcinoma, Non-Small-Cell Lung is a Phase 3 program (small_molecule) at MAIA Biotechnology with 2 ClinicalTrials.gov record(s).

Program details

Company
MAIA Biotechnology
Indication
Carcinoma, Non-Small-Cell Lung
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials